CEO, CFO of Missouri hospital allegedly received $100k in inappropriate reimbursement

The CEO and CFO of Ranken Jordan Pediatric Bridge Hospital in Maryland Heights, Mo., resigned last week after the hospital board discovered the executives violated the hospital’s paid time off policy. The two received more than $100,000 combined in inappropriate reimbursement for paid time off, a spokesman for the hospital’s board told the St. Louis Business Journal.

Advertisement

The hospital board requested and accepted the resignations of president and CEO Lauri Tanner and vice president and CFO Jean Bardwell, effective May 2. The board’s executive committee initially identified the potential irregularities, and the board subsequently launched an investigation, which allegedly revealed the two executives violated hospital policy.

The board spokesman told the St. Louis Business Journal Ranken Jordan Pediatric Bridge Hospital’s fiscal year 2017 Form 990 will include $25,375 in taxes owed by Ms. Tanner and Ms. Bardwell. The applicable tax rate is 25 percent, meaning the two executives received more than $100,000 combined, according to the report.

The hospital’s Form 990 for fiscal year 2018, which will be filed next spring, will include a smaller tax amount that is still being calculated.

Ranken Jordan Pediatric Bridge Hospital COO Brett Moorehouse was named interim president and CEO, and a hospital board member is serving as interim CFO.

More articles on legal and regulatory issues:

12 latest healthcare industry lawsuits, settlements
4 found guilty in insider trading case linked to CMS
Ex-Florida hospital CEO indicted in $1M scheme

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.